Prices delayed by at least 15 minutes | Print


Pacific Biosciences of California (PACB)

Common Shares
Sell: $1.55|Buy: $1.57|Change: 0.09 (6.16%)

Open 

$1.47


Previous close 

$1.46


Trade high 

$1.67


Volume 

16,879,745


Year high 

$14.55


Year low 

$1.25


Dividend yield 

-


Market capitalisation 

$415.33 mn


P/E ratio 

175.44


ISIN 

US69404D1081


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 19/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Pacific Biosciences of California+ 6.16
More...

Company profile

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.